CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 105 filers reported holding CYTEK BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,309,222 | -31.3% | 1,142,975 | +6.4% | 0.00% | -50.0% |
| Q2 2023 | $9,177,494 | +3.2% | 1,074,648 | +11.0% | 0.00% | 0.0% |
| Q1 2023 | $8,894,908 | -7.3% | 967,890 | +3.0% | 0.00% | 0.0% |
| Q4 2022 | $9,596,858 | -29.3% | 939,947 | +2.0% | 0.00% | -33.3% |
| Q3 2022 | $13,567,000 | +52.6% | 921,669 | +11.2% | 0.00% | +50.0% |
| Q2 2022 | $8,890,000 | +16.6% | 828,616 | +17.1% | 0.00% | +100.0% |
| Q1 2022 | $7,627,000 | +192.4% | 707,463 | +342.7% | 0.00% | – |
| Q4 2021 | $2,608,000 | -15.3% | 159,805 | +11.1% | 0.00% | -100.0% |
| Q3 2021 | $3,080,000 | – | 143,859 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,300,000 | $13,273,000 | 8.92% |
| Miura Global Management | 780,000 | $7,963,800 | 4.01% |
| RA Capital Management | 13,381,054 | $136,620,561 | 2.77% |
| HHLR ADVISORS, LTD. | 8,684,530 | $88,669,051 | 1.87% |
| Brown Capital Management | 5,107,878 | $52,151,434 | 0.86% |
| Perceptive Advisors | 1,289,534 | $13,166,142 | 0.37% |
| Hillsdale Investment Management Inc. | 344,529 | $3,517,641 | 0.30% |
| PURA VIDA INVESTMENTS, LLC | 420,749 | $4,295,847 | 0.22% |
| FOX RUN MANAGEMENT, L.L.C. | 19,881 | $202,985 | 0.08% |
| INNOVIS ASSET MANAGEMENT LLC | 14,565 | $148,709 | 0.07% |